Universal eryhrodermia, KELA reimbursement

L12_ERYTHRO_KELA

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

KELA reimbursements: KELA codes 134

280

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

280

diagram downward connector

Check minimum number of events None

280

diagram downward connector

Include endpoints None

280

diagram downward connector
L12_ERYTHRO_KELA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 270 98 172
Unadjusted prevalence (%) 0.09 0.06 0.13
Mean age at first event (years) 48.16 45.28 49.80

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Cumulative Incidence

Correlations

Index endpoint: L12_ERYTHRO_KELA – Universal eryhrodermia, KELA reimbursement
GWS hits: 2

Survival analyses between endpoints

Plot

before Universal eryhrodermia, KELA reimbursement
after Universal eryhrodermia, KELA reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Universal eryhrodermia, KELA reimbursement